Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,167
datasets available to search
ShareScore release 0.9.0
Dataset results
2,167 results for “Interferons”
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
ClinicalTrials.gov study NCT00631371. IPD Sharing: Not stated. Countries: 30. Publications: 4.
A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
ClinicalTrials.gov study NCT02069899. IPD Sharing: NO. Countries: 5. Publications: 3.
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
ClinicalTrials.gov study NCT02962960. IPD Sharing: NO. Countries: 4. Publications: 1.
Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
ClinicalTrials.gov study NCT02194998. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
ClinicalTrials.gov study NCT00436826. IPD Sharing: Not stated. Countries: 4. Publications: 2.
SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00083889. IPD Sharing: Not stated. Countries: 11. Publications: 6.
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)
ClinicalTrials.gov study NCT01095835. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy
ClinicalTrials.gov study NCT00738530. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
ClinicalTrials.gov study NCT01471574. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C
ClinicalTrials.gov study NCT00491244. IPD Sharing: Not stated. Countries: 1. Publications: 31.
Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
ClinicalTrials.gov study NCT00038649. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00467077. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00003656. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genetic and Biochemical Markers of Interferon-Induced Depression.
ClinicalTrials.gov study NCT00252538. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
ClinicalTrials.gov study NCT02097849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
ClinicalTrials.gov study NCT00605215. IPD Sharing: Not stated. Countries: 19. Publications: 2.
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
ClinicalTrials.gov study NCT00246324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
ClinicalTrials.gov study NCT00529568. IPD Sharing: Not stated. Countries: 23. Publications: 3.
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologis
ClinicalTrials.gov study NCT02106156. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
ClinicalTrials.gov study NCT00491179. IPD Sharing: Not stated. Countries: 1. Publications: 29.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.